Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emmanuel Luigi"'
Autor:
Bertrand Millat, Audrey Baron-Gutty, Valentin Daucourt, Hugo Bertillot, Estelle Aragona, Carlos El Khoury, Isabelle Gasquet, P. Occelli, Emmanuel Luigi, Julien Delonca, Philippe Michel, Isabelle Ray-Coquard, Laurie Fraticelli, Pierre Parneix, Jean-Patrick Lajonchere, Alain-Michel Ceretti, Olivier Farges, Antoine Duclos
Publikováno v:
International Journal for Quality in Health Care
International Journal for Quality in Health Care, Oxford University Press (OUP), 2020, 32 (1), pp.12-19. ⟨10.1093/intqhc/mzz090⟩
International Journal for Quality in Health Care, Oxford University Press (OUP), 2020, 32 (1), pp.12-19. ⟨10.1093/intqhc/mzz090⟩
Background Quality indicators (QI) are mandatory in French hospitals. After a decade of use, the Ministry of Health set up an expert workgroup to enhance informed decision-making regarding currently used national QI, i.e. to propose a decision of wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442f02a3125b39f5342dacdf3f5cbc3d
https://doi.org/10.1093/intqhc/mzz090
https://doi.org/10.1093/intqhc/mzz090
Autor:
Philippe Lechat, Camille Dutot, Florence Favrel-Feuillade, Laurent Mairot, Christophe Roussel, Emmanuel Luigi, Iliona Hounliasso, Karine Szwarcensztein, Albane Degrassat-Théas, Hélène Coulonjou, Laurent Piazza, Cécile Vienney, Anne-Aurélie Epis de Fleurian, Thao Nguyen, Nicolas Martelli, Régis Beuscart, Cyril Puc
Publikováno v:
Therapies. 72:115-123
Hospital-based health technology assessment (HTA) guides decisions as to whether new healthcare products should be made available within hospital structures. Its extension to medical devices (MDs) makes it possible to analyse several relevant aspects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9df31798043d045f11a8bd581d48b9d9
https://doi.org/10.1016/j.therap.2017.01.002
https://doi.org/10.1016/j.therap.2017.01.002
Autor:
Karine Szwarcensztein, Hélène Coulonjou, Philippe Lechat, Laurent Mairot, les participants à la table ronde no de Giens Xxxii, Iliona Hounliasso, Nicolas Martelli, Emmanuel Luigi, Albane Degrassat-Théas, Camille Dutot, Cyril Puc, Christophe Roussel, Florence Favrel-Feuillade, Régis Beuscart, Anne-Aurélie Epis de Fleurian, Cécile Vienney, Thao Nguyen, Laurent Piazza
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2017, 72 (1), pp.105-113. ⟨10.1016/j.therap.2016.11.056⟩
Thérapie, EDP Sciences, 2017, 72 (1), pp.105-113. ⟨10.1016/j.therap.2016.11.056⟩
Resume L’evaluation des technologies de sante (ETS) en milieu hospitalier est une aide a la decision pour l’integration de produits de sante a la structure hospitaliere. Appliquee aux dispositifs medicaux (DM), elle permet d’apprehender plusieu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd8c32342695289fb5c93b37605a586
https://doi.org/10.1016/j.therap.2016.11.056
https://doi.org/10.1016/j.therap.2016.11.056
Autor:
Christophe Roussel, Cédric Carbonneil, Antoine Audry, Stéphane Burtey, Sandrine Faré, François Langevin, Stéphane Laroche, Emmanuel Luigi, Nicolas Martelli, Hubert Méchin, Grégoire Mercier, Frédéric Rupprecht, Karine Szwarcensztein, André Tanti, Sébastien Woynar, Catherine Zaidman
Publikováno v:
Therapies. 71:69-82
Resume L’evaluation des technologies de sante (ETS) est en pleine evolution et l’interet de prendre en compte des domaines non cliniques est croissant. Si l’aspect medico-economique est communement reconnu, l’evaluation de l’impact organisa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bc03e8917edce82b43943a6bf0a094f
https://doi.org/10.1016/j.therap.2015.12.003
https://doi.org/10.1016/j.therap.2015.12.003
Autor:
Karine Szwarcensztein, Christophe Roussel, Antoine Audry, André Tanti, Hubert Méchin, Nicolas Martelli, Sandrine Fare, Stéphane Burtey, Emmanuel Luigi, Frédéric Rupprecht, François Langevin, Stéphane Laroche, Cédric Carbonneil, Grégoire Mercier, Sébastien Woynar, Catherine Zaidman
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, EDP Sciences, 2016, 71 (1), pp.83-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, EDP Sciences, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, EDP Sciences, 2016, 71 (1), pp.83-96. ⟨10.1016/j.therap.2016.01.003⟩
Thérapie, 2016, 71, pp.69-96. ⟨10.1016/j.therap.2016.01.003⟩
International audience; Health technology assessment (HTA) is a rapidly developing area and the value of taking non-clinical fields into consideration is growing. Although the health-economic aspect is commonly recognised, evaluating organisational i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e251290120c63557e1428c4ead5ecfd1
https://hal-amu.archives-ouvertes.fr/hal-01464976
https://hal-amu.archives-ouvertes.fr/hal-01464976
Autor:
Claude Messiaen, Albane de Carrara, Rémy Choquet, Emmanuel Luigi, Paul Landais, Meriem Maaroufi
Publikováno v:
Journal of the American Medical Informatics Association
Journal of the American Medical Informatics Association, BMJ Publishing Group, 2015, 22 (1), pp.76-85. ⟨10.1136/amiajnl-2014-002794⟩
Journal of the American Medical Informatics Association, 2015, 22 (1), pp.76-85. ⟨10.1136/amiajnl-2014-002794⟩
Journal of the American Medical Informatics Association, BMJ Publishing Group, 2015, 22 (1), pp.76-85. ⟨10.1136/amiajnl-2014-002794⟩
Journal of the American Medical Informatics Association, 2015, 22 (1), pp.76-85. ⟨10.1136/amiajnl-2014-002794⟩
Background Although rare disease patients make up approximately 6–8% of all patients in Europe, it is often difficult to find the necessary expertise for diagnosis and care and the patient numbers needed for rare disease research. The second French
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f3b3483683ac55a3c455cece998a051
https://europepmc.org/articles/PMC4433369/
https://europepmc.org/articles/PMC4433369/